altRX vs Vytora Health
altRX costs $1 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vytora Health
Best for: moving between compounded and brand without changing seller
Visit Vytora Health →If you are choosing between altRX and Vytora Health, the first difference is cost: altRX is $1 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Vytora Health leads our six-part score, 8.3 to 6.7. One of the two has an FDA warning letter on record, covered below.
altRX vs Vytora Health price
altRX is the cheaper way in: $149 a month against $150 a month at Vytora Health. That is $1 less each month (1% lower), or about $12 over a year of treatment.
Drug by drug: Semaglutide is cheaper at altRX ($149 a month vs $150 a month); tirzepatide is cheaper at Vytora Health ($200 a month vs $249 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format they match: each offers compounded injections and brand-name pens.
Where each one treats patients
altRX does not publish where it ships, and Vytora Health lists 51 states.
Pricing
altRX
Vytora Health
What each price covers
Both prices cover the clinician visit, the medication itself and shipping.
altRX is silent on lab work and coaching.
Vytora Health is silent on lab work and coaching.
altRX
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Vytora Health
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Vytora Health scores 8.3 and altRX 6.7 out of 10.
Vytora Health is stronger on value (6.6 vs 5.0), trust & safety (8.5 vs 3.5) and accessibility (10.0 vs 5.0).
Effectiveness, user experience and support are within half a point.
altRX
6.7/10
Vytora Health
8.3/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent altRX a warning letter dated June 8, 2026 (letter 728236), and it is still open.
Vytora Health has no FDA warning letter on record with us.
Features & Coverage
| Feature | altRX | Vytora Health |
|---|---|---|
| Starting Price | ✓$149/mo | $150/mo |
| Features | 8 features | 8 features |
| States Available | Not disclosed | 51 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About altRX
Compounded plans open at $149 for semaglutide and $249 for tirzepatide. Branded medication runs $1,149-$1,579, a figure that already contains the consult and the shipping. Every one of the four FDA-approved brands is stocked, Mounjaro, Ozempic, Wegovy and Zepbound, which no other entry in our directory matches. altRX works in both modalities, holds LegitScript certification, and prints the FDA compounded-medication disclaimer.
Read our full altRX review →About Vytora Health
Semaglutide compounded runs $180/mo, or $150 if bought as a 3-month bundle; tirzepatide is $249/mo and $200 bundled the same way. Coverage takes in 50 states and DC. Brand-name Mounjaro and Zepbound are stocked too, along with the peptides NAD+ and sermorelin. Two pharmacy partners get named in public, Vials Pharmacy and Greenwich Biosciences, and the physician group behind the operation is disclosed, which few in this category do.
Read our full Vytora Health review →Pros & Cons
altRX
What we like
- Tirzepatide costs $1249 a month, close to the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
Watch-outs
- Semaglutide costs $1149 a month, 16% above the $990 median for brand-name semaglutide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued altRX a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Vytora Health
What we like
- Semaglutide costs $150 a month, 18% below the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $200 a month, 20% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Vytora Health
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Vytora Health wins this one, 8.3 to 6.7, above all for moving between compounded and brand without changing seller. altRX undercuts it by $1 a month, so if the monthly bill is what decides it, altRX is the pick. altRX fits better if semaglutide from $1149/month is your priority.
Choose altRX if…
You want semaglutide from $1149/month and an opening price near $149 a month.
Choose Vytora Health if…
You want moving between compounded and brand without changing seller and an opening price near $150 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →altRX vs Vytora Health: FAQ
Close alternatives to altRX and Vytora Health
- altRX vs Gala
- altRX vs Sprout Health
- altRX vs Aquivia Health
- Vytora Health vs Gala
- Vytora Health vs Sprout Health
- Vytora Health vs Aquivia Health
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.